Form 4 for BSX Boston Scientific
Accepted 2022-11-21 00:00:00 ET · period of report 2022-11-18 · accession 0001225208-22-011792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-21 | 2022-11-18 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $42.72 | -15.0K | 57.5K | -21% | -$638.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-18 | S | D | 14,952 | $42.72 | 57,533.99 | D | — | — | (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.701 to $42.755 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |